DE69721055D1 - Verfahren zur herstellung von depsipeptiden und zwischenprodukten davon - Google Patents

Verfahren zur herstellung von depsipeptiden und zwischenprodukten davon

Info

Publication number
DE69721055D1
DE69721055D1 DE69721055T DE69721055T DE69721055D1 DE 69721055 D1 DE69721055 D1 DE 69721055D1 DE 69721055 T DE69721055 T DE 69721055T DE 69721055 T DE69721055 T DE 69721055T DE 69721055 D1 DE69721055 D1 DE 69721055D1
Authority
DE
Germany
Prior art keywords
producing
depsipeptides
intermediate products
represent
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69721055T
Other languages
English (en)
Other versions
DE69721055T2 (de
Inventor
Ryo Yamanishi
Masaru Ohgaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of DE69721055D1 publication Critical patent/DE69721055D1/de
Application granted granted Critical
Publication of DE69721055T2 publication Critical patent/DE69721055T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69721055T 1996-10-07 1997-09-24 Verfahren zur herstellung von depsipeptiden und zwischenprodukten davon Expired - Lifetime DE69721055T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP28604796 1996-10-07
JP28604796 1996-10-07
PCT/JP1997/003417 WO1998015523A1 (fr) 1996-10-07 1997-09-24 Procede de production de derives de depsideptides et leurs nouveaux intermediaires

Publications (2)

Publication Number Publication Date
DE69721055D1 true DE69721055D1 (de) 2003-05-22
DE69721055T2 DE69721055T2 (de) 2004-02-19

Family

ID=17699289

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69721055T Expired - Lifetime DE69721055T2 (de) 1996-10-07 1997-09-24 Verfahren zur herstellung von depsipeptiden und zwischenprodukten davon

Country Status (12)

Country Link
US (1) US6235875B1 (de)
EP (1) EP0953563B1 (de)
JP (1) JP4035852B2 (de)
CN (1) CN1205177C (de)
AT (1) ATE237583T1 (de)
BR (1) BR9712279A (de)
CA (1) CA2267376C (de)
DE (1) DE69721055T2 (de)
DK (1) DK0953563T3 (de)
ES (1) ES2191852T3 (de)
PT (1) PT953563E (de)
WO (1) WO1998015523A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2177059T3 (es) * 1997-11-10 2002-12-01 Fujisawa Pharmaceutical Co Nuevo cristal de derivado de depsipetido y procedimiento de produccion.
EP1812036A2 (de) * 2004-11-17 2007-08-01 The University Of Chicago Histon-deacetylase-hemmer und anwendungsverfahren
LT3298027T (lt) 2015-05-20 2021-08-10 Boehringer Ingelheim Animal Health USA Inc. Antihelmintiniai depsipeptido junginiai
AU2016380868B2 (en) 2015-12-28 2019-11-28 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
CN110167921A (zh) 2016-11-16 2019-08-23 勃林格殷格翰动物保健美国公司 驱蠕虫缩肽化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69331414T2 (de) 1992-03-17 2002-08-08 Fujisawa Pharmaceutical Co., Ltd. Depsipeptide, herstellung und anwendung
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
AU686222B2 (en) 1993-09-06 1998-02-05 Astellas Pharma Inc. Cyclodepsipeptide compound
CN1162409C (zh) 1995-06-30 2004-08-18 藤泽药品工业株式会社 缩肽衍生物、其新型中间体以及中间体的制造方法

Also Published As

Publication number Publication date
JP4035852B2 (ja) 2008-01-23
CA2267376A1 (en) 1998-04-16
EP0953563B1 (de) 2003-04-16
WO1998015523A1 (fr) 1998-04-16
ES2191852T3 (es) 2003-09-16
CA2267376C (en) 2006-11-14
CN1205177C (zh) 2005-06-08
EP0953563A4 (de) 2001-05-16
PT953563E (pt) 2003-08-29
DK0953563T3 (da) 2003-07-28
BR9712279A (pt) 1999-08-31
CN1232446A (zh) 1999-10-20
US6235875B1 (en) 2001-05-22
DE69721055T2 (de) 2004-02-19
EP0953563A1 (de) 1999-11-03
ATE237583T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
ATE233730T1 (de) Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende mittel und verfahren zu ihrer herstellung
EP0685469A4 (de) Pf1022-derivate, cyclische depsipeptide.
DE69527429D1 (de) Verfahren zur herstellung von wasserfreien und hydrat-formen von antihistaminischen piperinderivaten, polymerphe und pseudomorphe davon
ATE121753T1 (de) Octapeptid oder heptapeptidderivate, verfahren zu deren herstellung sowie medikamente, die diese verbindungen enthalten und verwendung derselben.
PT768086E (pt) Tratamento de tinido utilizando agentes neuroprotectores
ATE317912T1 (de) Verfahren zur herstellung von beta-lactamen
DE59509910D1 (de) Verfahren zur Herstellung von Alkylhydrogenchlorsilanen
DE69721055D1 (de) Verfahren zur herstellung von depsipeptiden und zwischenprodukten davon
MX9305196A (es) Novedosos 2-sacarinilmetil aril carboxilatos utiles como inhibidores de enzima proteolitica y composiciones y metodos de su uso.
DE60131733D1 (de) Verfahren zur herstellung von (2s,3r,4s)-4-hydroxyisoleucin und analoga
ATE172956T1 (de) Fluorenonderivate, verfahren zu ihrer herstellung sowie wiederherstellungs- und schutzmittel für zentrale und periphere nervendegenerationen
DE59804277D1 (de) Verfahren zur Herstellung von 2,6-Pyridindicarbonsäureestern
DE50105413D1 (de) Verfahren zur Racemisierung von optisch aktiven Aminen
ATE85327T1 (de) Substituierte pyridylethanolamine, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer bei tieren.
ATE229504T1 (de) Verfahren zur herstellung von 3-amino-2-oxo- pyrrolidinen, zwischenprodukte und deren verwendung
DE69811893D1 (de) Verfahren zur herstellung von azetidin-2-carbonsäure und zwischenprodukten davon
DE59800581D1 (de) Verfahren zur Herstellung von Diacylimiden
NO984206L (no) Fremgangsmaate for fremstilling av N-beskyttende D-prolinderivater
DE59707004D1 (de) Verfahren zur Herstellung von 2-substituierten 5-Chlorimidazol-4-carbaldehyden
ATE253038T1 (de) Verfahren zur herstellung von n-acylaminosäuren
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
DE69819315D1 (de) Verfahren zur herstellung von piperidincarbonsäureamiden
ATE204582T1 (de) Von neurokininen abgeleitete pseudopeptide, verfahren für ihre herstellung und sie enthaltende pharmazeutische zubereitungen
ATE246182T1 (de) Verfahren zur herstellung von 1,4-benzodioxan- derivaten
ATE215561T1 (de) Methylsulfomycin 1, verfahren zu dessen herstellung und verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASTELLAS PHARMA INC., TOKIO/TOKYO, JP